Penn State Health shared a post on LinkedIn:
“Penn State Health Children’s Hospital is advancing the science of pediatric oncology on the national stage.
At this year’s Association of Pediatric Hematology/Oncology Nurses (APHON) Annual Conference, Suzanne Treadway, RN, presented on the safety profile in DFMO dosing for children with neuroblastoma.
Her work underscores the critical role of nurses in clinical research and in supporting children and families throughout clinical trials. By sharing Penn State’s expertise nationally, Suzanne is helping to move the field forward and improve the future of childhood cancer care.”
More Posts Featuring Penn State Health.